DNAtrix Announces the Appointment of David Liebowitz, M.D., Ph.D., as Chief Medical Officer

HOUSTON: HOUSTON, Sept. 14, 2021 /PRNewswire/ -- DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced the appointment of David Liebowitz, M.D., Ph.D., an industry veteran with over 20 years of experience in oncology drug and viral vaccine development, as chief medical officer. "We are thrilled to welcome...

Click to view original post